HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi Partners With Colombian Tech Firm Rappi To 'Transform' Healthcare In Latin America

Executive Summary

Sanofi Consumer Healthcare is utilizing emerging digital technology to take a bigger slice of the Latin American OTC market. Through a partnership deal, e-commerce and delivery firm Rappi will promote and sell Sanofi's brands to consumers across seven Latin American markets. 

You may also be interested in...



Zantac Recall And EU Regulatory Issues Hurt Sanofi In Q3

Recalling Zantac in North America over contamination concerns and tightening regulatory requirements in Europe combined to impede growth at Sanofi Consumer Healthcare in Q3. New CEO Paul Hudson says he is still taking time to get to know the business before making any strategic moves.

Going ‘Beyond The Pill’ – Sanofi To Partner With Digital Health Start-ups In Europe

Sanofi is looking to work with European start-ups to develop innovative consumer health solutions that go 'beyond the pill'. The French firm is partnering with Silicon Valley's Plug and Play to identify promising digital technologies in the allergy and nutrition spaces.

Digital Key To Sanofi’s Growth Plans

“Digital is transforming how consumers manage their own health and, importantly, how they interact with our business,” according to Sanofi Consumer Healthcare head Alan Main.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel